Shillong, August 19: The Pasteur Institute, Shillong Achieves National Accreditation for Molecular Diagnostics Laboratory and Regional Blood Centre A Landmark for Public Healthcare in Meghalaya in a historic first for public healthcare quality in Meghalaya, Pasteur Institute, Shillong, functioning under the Directorate of Health Services Medical & Research (DME&R), Government of Meghalaya, has become the first State government health facility to achieve national accreditation for two of its facilities — the Molecular Diagnostics Laboratory and the Regional Blood Centre.
The Molecular Diagnostics Laboratory at Pasteur Institute, Lawmali, Shillong, has been accredited by the National Accreditation Board for and Calibration Laboratories (NABL) under ISO 15189:2022 “Medical Laboratories: Requirements for Quality and Competence.”
The accreditation is valid from 27th July 2026 to 26th July 2030 and certifies the laboratory’s competence in Molecular Diagnostics, including Real-Time PCR-based testing (Closed System) for Mycobacterium Tuberculosis (MTB) with Non-Tuberculous Mycobacteria (NTM) across a wide range Of clinical includingblood, CSF, tissue, sputum, body fluids, and Other biological samples.
Simultaneously, the Regional Blood Centre, Pasteur Institute, Lawmali, Shillong, has been accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), a constituent board of the Quality Council of India, for compliance with NABH accreditation standards on Blood Banks and Blood Centres and Transfusion Services, valid from 23rd July 2026 to 22nd July 2029.
A historic milestone for Government Healthcare in Meghalaya, this marks the first time a state government-run health facility has attained such national-level, dual accreditation. These accreditations mark a major achievement for the state’s public health infrastructure, stationing Pasteur Institute, Shillong among a select group of government laboratories in the region to meet globally ILAC-MRA-backed quality benchmarks (NABL) and national healthcare quality standards (NABH).
Such accreditation is not merely a certification but a rigorous, independent validation of the laboratory’s testing accuracy, staff competence, equipment calibration, biosafety protocols, and overall quality management systems assurances that directly translate into safer, more reliable diagnosis and treatment for the people of Meghalaya.
Quality accreditation of this nature strengthens public confidence in government healthcare services, reduces diagnostic errors, ensures traceability and consistency of results, and enables continuity of care through internationally benchmarked protocols. For a state healthcare system, achieving such accreditation also opens avenues for participation in national health programmes, referral networks, and that require testing standards.
Recognizing the Contributors This achievement reflects the sustained vision and supm»rt of the Dirwtorate of Health Services Education and Research (DME&R), Government of Meghalaya, whose administrative leadership and commitment to quality healthcare infrastructure made this accreditation process possible.
The credit for this accomplishment also goes to the dedicated doctors, scientific officers, technical staff, and support personnel of the Molecular Diagnostics Laboratory and the Regional Blood Centre, Pasteur Institute, whose meticulous adherence to quality protocols, documentation efforts, and commitment to patient safety over an extended assessment process enabled the institute to meet these stringent national standards.
